GTBPVSULBI• 12 Months (Normalized)
GTBP vs ULBI (GT Biopharma Inc. vs Ultralife Corporation)
Showing Closing Date Range from Sep 30, 2025 to Sep 30, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GTBP Performance $6.88
+1071.21%
GT Biopharma Inc.
Normalized Baseline0.00%
ULBI Performance $6.16
+%
Ultralife Corporation
Normalized Baseline0.00%
Alpha Spread Margin GTBP LEADS
+1071.21 pts
GTBP outperforming by 1071.21 percentage points
GTBPULBI
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GTBP ULBI
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | GTBP Price | GTBP Gain (%) | ULBI Price | ULBI Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 29, 2026 | $6.88 | +1071.21% | $- | - | |
| Sep 28, 2026 | $6.80 | +1058.43% | $- | - | |
| Sep 25, 2026 | $6.89 | +1073.76% | $6.16 | -9.68% | +1083.44% |
| Sep 24, 2026 | $6.83 | +1063.54% | $6.05 | -11.29% | +1074.83% |
| Sep 23, 2026 | $7.10 | +1109.54% | $5.90 | -13.49% | +1123.03% |
| Sep 22, 2026 | $- | $5.70 | -16.42% | - | |
| Sep 21, 2026 | $7.18 | +1123.17% | $5.64 | -17.30% | +1140.47% |
| Sep 18, 2026 | $7.16 | +1119.76% | $5.65 | -17.16% | +1136.92% |
| Sep 17, 2026 | $7.49 | +1175.98% | $5.58 | -18.18% | +1194.16% |
| Sep 16, 2026 | $7.81 | +1230.49% | $5.45 | -20.09% | +1250.58% |
| Sep 15, 2026 | $9.00 | +1433.22% | $5.44 | -20.23% | +1453.45% |
| Sep 14, 2026 | $11.63 | +1881.26% | $5.56 | -18.48% | +1899.74% |
| Sep 11, 2026 | $8.61 | +1366.78% | $5.60 | -17.89% | +1384.67% |
| Sep 10, 2026 | $6.18 | +952.81% | $5.65 | -17.16% | +969.97% |
| Sep 09, 2026 | $5.98 | +918.74% | $5.63 | -17.45% | +936.19% |
Page 1 of 17